GenVec

GenVec Announces Second Quarter 2009 Results Conference Call

...09 on Thursday, August 6, 2009 after market close. genvec will hold a conference call at 10:00 a.m. EDT on F... and click on "Webcasts and Data." About genvec GenVec, Inc. is a biopharmaceutical company de...l cancer, rectal cancer, and head and neck cancer. genvec also uses its proprietary adenovector technology t...

GenVec Receives Grant for Malaria Vaccine Program

...s GenVec. This funding supports the advancement of genvec technology by moving genvec into the antigen discovery phase of vaccine develo...ne development. Using the funding from this grant, genvec will be collaborating with the U.S. Naval Medical ...

GenVec in Medical Technology

TNFerade(TM) Phase III Data Presented at ASCO

... treatment of locally advanced pancreatic cancer. genvec is developing TNFerade for use in combination with...r the treatment of various cancers. About genvec GenVec, Inc. is a biopharmaceutical company...l cancer, rectal cancer, and head and neck cancer. genvec also uses its proprietary adenovector technology t...

GenVec Announces Multiple Presentations at the American Society of Tropical Medicine and Hygiene Meeting

...Presentations Will Highlight Research Conducted in genvec Malaria Vaccine Program GAITHERSBURG, Md....search conducted in this program, will be given by genvec scientists. Additional presentations, to be given by genvec collaborators, will provide updates on malaria vac...

GenVec Announces New Research at AACR on Selectivity and Mechanism of Action of TNF-Based Anti-Cancer Therapy

...III trial for locally advanced pancreatic cancer. genvec researchers presented a poster entitled, "Selectiv... the treatment of cancer," added Dr. King. About genvec GenVec, Inc. is a biopharmaceutical company deve...I studies are in progress in head and neck cancer. genvec also uses its proprietary adenovector technology t...

GenVec Presents Research on New Ad35 Adenovector at ARVO

...eins in the eye over a period of several months. genvec researchers compared the duration of expression in...ive and more convenient treatment for AMD. About genvec GenVec, Inc. is a biopharmaceutical company deve...I studies are in progress in head and neck cancer. genvec also uses its proprietary adenovector technology t...

GenVec Announces Update of Safety and Efficacy Data from Pivotal Phase II/III PACT Study of TNFerade at ASCO

...then follow the link to Webcasts and Data. About genvec GenVec, Inc. is a biopharmaceutical company deve...I studies are in progress in head and neck cancer. genvec also uses its proprietary adenovector technology t...nal and pandemic flu. Additional information about genvec is available at www.genvec.com and in the Company'...

GenVec in Biological News

Progress made in HIV vaccine development

...d colleagues from the National Institutes of Health IH Vaccine Research Center in Maryland, the Fred Hutchinson Cancer Research Center in Seattle, and genvec Incorporated tested two possible HIV vaccines with the hope of producing an immune response in healthy, uninfected adults. One was a plasmid DNA-base...

GenVec in Biological Technology

GenVec Reports Second Quarter 2009 Financial Results

....com/cgi-bin/prnh/20081205/DC50112LOGO ) genvec reported a net loss of $4.8 million ($0.05 per sha...ram as compared to the prior year periods. genvec ended the second quarter of 2009 with $12.6 millio...fficer. "In spite of the difficult economic times, genvec continues to make strides in its therapeutic and v...

GenVec Expands Contract Supporting Malaria Vaccine Program

..., head of GenVec's malaria program. About genvec GenVec, Inc. is a biopharmaceutical compa...l cancer, rectal cancer, and head and neck cancer. genvec also uses its proprietary adenovector technology t...rus (RSV), and HSV-2. Additional information about genvec is available at www.genvec.com and in the comp...

GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants

...clusive placement agent in this transaction. genvec will use proceeds from the offering for further de...he securities described above are being offered by genvec pursuant to a registration statement previously fi...r, solicitation, or sale is unlawful. About genvec GenVec, Inc. is a biopharmaceutical company de...